Posts

Showing posts with the label Alfa ChemistryP harmaceutical Development

CDMO Services Released by Alfa Chemistry Offer New Possibilities for Pharmaceutical Development & Manufacturing

Known for its competence, responsibility, and innovative capability in chemical supply, Alfa Chemistry recently unveiled its new role as a CDMO service  provider for pharmaceutical companies worldwide. Contract Development and Manufacturing Organization, abbreviated as CDMO, is a preferential way for a majority of pharmaceutical companies to outsource ongoing drug development and drug manufacturing projects. “With advanced facilities, we are capable of providing CMO, CRO, and CDMO services globally for the design, development, and production of various biologic drug products, including but not limited to recombinant proteins, ADCs, monoclonal antibodies, and bispecific antibodies,” said the Marketing Chief of Alfa Chemistry. “Our technical expertise in biomanufacturing allows us to respond swiftly and solve problems that puzzle our clients efficiently.” The list of CDMOs services provided by Alfa Chemistry covers nearly every aspect of drug development and manufacturing and is main...